Inflammatory Bowel Diseases (IBD)

DBCOND0069946Digestive System DiseasesInfections

Inflammatory Bowel Diseases (IBD) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Inflammatory Bowel Disease · Inflammatory Bowel Diseases · Inflammatory Bowel Disease (IBD) · IBD · IBD (Inflammatory Bowel Disease)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0023374SNOMED CT155759008MedDRA10021184UMLSC0021390

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
576Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Inflammatory Bowel Diseases (IBD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In